Recombinant Human Prolactin for Lactation Induction

Withdrawn before enrolling · Phase 2

Conditions studied: Lactation

In brief

The purpose of the study is to assess the safety and determine the effects of the hormone prolactin on lactation (breast milk production).

Key facts

Study ID

NCT00181649

Run by

Massachusetts General Hospital

People needed

0

Starts

2006-09-01

Expected to finish

2011-05-01

Last updated by the study team

2013-05-09

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Healthy, non-postpartum women, aged 18-45 years, who desire to lactate for their adoptive children
• Normal thyroid-stimulating hormone (TSH) and prolactin level
• Normal adrenal gland function or taking physiological glucocorticoid replacement
• No medical illnesses that contraindicate breastfeeding
• HIV negative
• Normal breast development

You may not qualify if…

• Use of medications known to increase prolactin
• Anatomical breast abnormalities
• Previous mammoplasty or breast augmentation
• Current use of hormonal contraception
• Allergies to mannitol
• Medications contraindicated for breastfeeding mothers

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.